SCHEMBL7146883

SCHEMBL7146883

CC(C)(C)OC(=O)Nc1cc(COC(=O)C(C)(C)C)c(C#Cc2ccccc2)cc1[N+](=O)[O-]

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.36
MAPK1 P28482 2/20 0.36
RAB9A P51151 2/20 0.36
HTT P42858 2/20 0.36
ALDH1A1 P00352 2/20 0.36
GLA P06280 1/20 0.36
CASP3 P42574 1/20 0.36
SENP8 Q96LD8 1/20 0.36
SENP7 Q9BQF6 1/20 0.36
SENP6 Q9GZR1 1/20 0.36
MAPT P10636 3/20 0.35
MMP2 P08253 1/20 0.35
MMP9 P14780 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
POLB P06746 1/20 0.35
LMNA P02545 1/20 0.35
PTGES O14684 1/20 0.35
BCL2 P10415 1/20 0.34
ALOX5 P09917 1/20 0.34
ITGA4 P13612 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7148597 0.91 MMP2 (0.38) NPC1MAPK1RAB9AHTTALDH1A1
SCHEMBL6167226 0.89 NPC1 (0.38) NPC1MAPK1RAB9AHTTALDH1A1
SCHEMBL7141833 0.86 LMNA (0.39) NPC1MAPK1RAB9AHTTALDH1A1
SCHEMBL7142233 0.86 PDGFRB (0.37) NPC1MAPK1RAB9AHTTALDH1A1
SCHEMBL7140278 0.85 PTGES (0.36) NPC1RAB9AALDH1A1GLAMAPT
SCHEMBL7140140 0.83 MAPT (0.43) NPC1MAPK1RAB9AHTTALDH1A1
SCHEMBL7142921 0.82 NPC1 (0.39) NPC1MAPK1RAB9AHTTALDH1A1
SCHEMBL7147995 0.82 ALDH1A1 (0.36) NPC1RAB9AALDH1A1MAPTMMP2
SCHEMBL7138026 0.82 MAPT (0.41) NPC1MAPK1RAB9AHTTALDH1A1
SCHEMBL7146760 0.81 ALDH1A1 (0.39) NPC1MAPK1RAB9AHTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224174-B1 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2003-09-17 EP disclosed
EP-1224174-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2002-07-24 EP disclosed
US-6407094-B1 4-5-DIDEHYDRO-1,5-BENZODIAZEPIN-2-ONE DERIVATIVES; PSYCHOLOGICAL, NERVOUS SYSTEM, AND BRAIN DISORDERS; COGNITION ACTIVATORS; ALZHEIMER*S DISEASE, SCHIZOPHRENIA HOFFMANN-LA ROCHE INC. 2002-06-18 US disclosed
WO-2001029011-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2001-04-26 WO disclosed